3 incredible ASX 200 growth shares to buy: analysts

Lithium, healthcare, and technology are where analysts are urging investors to put their money…

| More on:
A share market analyst looks at his computer screen in front of him showing ASX share price movements

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors that have a higher than average tolerance for risk might want to check out the ASX growth shares listed below.

These shares have been named as buys and tipped to climb meaningfully from current levels. Here's what you need to know:

ResMed Inc. (ASX: RMD)

The first ASX 200 growth share to buy could be ResMed. It is a medical device company with a focus on the sleep disorder treatment market. It has been tipped to continue growing at a solid rate long into the future thanks to its large and growing market opportunity. The latter is estimated to comprise almost one billion people with sleep apnoea globally and a little under half a billion people suffering from chronic obstructive pulmonary disease (COPD). And as the majority of these people are undiagnosed, ResMed has a long runway for growth.

Morgans is bullish on ResMed and has an add rating and $37.24 price target on its shares.

Pilbara Minerals Ltd (ASX: PLS)

Pilbara Minerals could be another ASX 200 growth share to buy. It is one of the largest lithium miners in the world and the owner of a collection of high quality assets. Morgans is also very positive on Pilbara Minerals and believes its shares been oversold recently. Especially given its belief that "demand in the Chinese market could increase [for lithium] from March onwards."

Morgans currently has an add rating and $4.70 price target on this lithium miner's shares.

Xero Limited (ASX: XRO)

A final ASX 200 growth share that has been named as a buy is Xero. It is a cloud-based accounting solution provider to millions of small businesses globally. While the company is generating significant recurring revenue from its 3.3 million subscribers, it is nothing compared to what it could be in the future. Goldman Sachs estimates that it has a total addressable market of 100 million, which gives Xero a huge growth runway over the next decade or two.

Goldman Sachs has a buy rating and $109.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »